$MRNA - biotechs are the kings of releasing info selectively & mkt lovin it. Let& #39;s see: 1) You need a booster 4 wks after the 1st shot or else you don& #39;t get the protection; 2) the study enrolled (only) 45 volunteers ages 18-55 - no details on older patients who get hit the most; https://twitter.com/adamfeuerstein/status/1283144532297519104">https://twitter.com/adamfeuer...
3) They don& #39;t know what level of antibodies is needed to avoid infection; 4) a few patients didn& #39;t take the 2nd shot. So <15 pts in the 100 dose level to go on. MKT jumps on ANY vaccine news no matter if vetted or not or likely or not. Day traders & momentum in charge...
4) No mention of how the 600 pts are doing in the ph 2 trial; 5) safety concerns-adverse side effects-are actually high (if this weren& #39;t so deadly to older people, some would care; unclear if pple wil take it anyway - 2 doses are hard) 6) 45 patients is the new critical mass now?
And lastly, while this is no certainty of future results, $MRNA has never produced a commercially viable product.
At times like these it& #39;s good to review what the FDA says - https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-action-help-facilitate-timely-development-safe-effective-covid">https://www.fda.gov/news-even... - "the FDA strongly encourages the inclusion of diverse populations in all phases of clncl dvlpmnt, including populations most affected by COVID-19, specifically racial & ethnic minorities..."